These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31335260)

  • 1. Persistent Heterogeneous Liver Enhancement after US Contrast Material Injection.
    Vij A; Fetzer DT
    Radiology; 2019 Sep; 292(3):539. PubMed ID: 31335260
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast enhanced ultrasound for focal liver lesions: how accurate is it?
    Barr RG
    Abdom Radiol (NY); 2018 May; 43(5):1128-1133. PubMed ID: 28718042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bolus versus continuous infusion of microbubble contrast agent for liver ultrasound by using an automatic power injector in humans: A pilot study.
    Quaia E; Gennari AG; Angileri R; Cova MA
    J Clin Ultrasound; 2016; 44(3):136-42. PubMed ID: 26302446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
    Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
    Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contrast medium-supported sonography of the liver--a challenge to German radiology].
    Albrecht T
    Rofo; 2003 Jul; 175(7):889-91. PubMed ID: 12847642
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneous delayed enhancement of hepatic parenchyma after intravenous infusion of sonographic contrast agent: a new hypothesis.
    Caruso G; Martegani A; Aiani L; Borghi C; Verderame F; Campisi A; Salvaggio G; Lagalla R; Cardinale AE
    Radiol Med; 2007 Feb; 112(1):56-63. PubMed ID: 17310291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound in the characterization of complex cystic focal liver lesions.
    Corvino A; Catalano O; Setola SV; Sandomenico F; Corvino F; Petrillo A
    Ultrasound Med Biol; 2015 May; 41(5):1301-10. PubMed ID: 25666723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of focal liver lesions with contrast-enhanced ultrasound.
    Piscaglia F; Lencioni R; Sagrini E; Pina CD; Cioni D; Vidili G; Bolondi L
    Ultrasound Med Biol; 2010 Apr; 36(4):531-50. PubMed ID: 20350680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the editor: prolonged heterogeneous liver enhancement on contrast-enhanced ultrasound.
    Piskunowicz M; Kosiak W; Batko T
    Ultraschall Med; 2015 Feb; 36(1):74. PubMed ID: 25654498
    [No Abstract]   [Full Text] [Related]  

  • 11. "Hot topics" in Contrast-Enhanced Ultrasound (CEUS)--introduction.
    Mostbeck G
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S1-2. PubMed ID: 22723023
    [No Abstract]   [Full Text] [Related]  

  • 12. Visualization of liver lesions in standardized video-documented ultrasonography - inter-observer agreement and effect of contrast injection.
    Stenman C; Glavas R; Davidsson J; Knutsson A; Smedby Ö
    Med Ultrason; 2015 Dec; 17(4):437-43. PubMed ID: 26649336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.
    Piscaglia F; Nolsøe C; Dietrich CF; Cosgrove DO; Gilja OH; Bachmann Nielsen M; Albrecht T; Barozzi L; Bertolotto M; Catalano O; Claudon M; Clevert DA; Correas JM; D'Onofrio M; Drudi FM; Eyding J; Giovannini M; Hocke M; Ignee A; Jung EM; Klauser AS; Lassau N; Leen E; Mathis G; Saftoiu A; Seidel G; Sidhu PS; ter Haar G; Timmerman D; Weskott HP
    Ultraschall Med; 2012 Feb; 33(1):33-59. PubMed ID: 21874631
    [No Abstract]   [Full Text] [Related]  

  • 14. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: a pilot animal study.
    Li J; Dong BW; Yu XL; Wang XH; Li CF
    J Ultrasound Med; 2005 Jul; 24(7):975-83. PubMed ID: 15972712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast-enhanced ultrasound for characterisation of focal liver lesions, practical advice].
    Fröhlich E; Jenssen C; Schuler A; Dietrich CF
    Z Gastroenterol; 2015 Sep; 53(9):1099-107. PubMed ID: 26367027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal liver lesions: one more example of discordance between contrast-enhanced sonography and CT pattern of enhancement.
    Francica G; Lapiccirella G
    AJR Am J Roentgenol; 2008 Mar; 190(3):W222; author reply W223. PubMed ID: 18287417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ultrasound contrast agents for liver diagnostics].
    Lemke AJ; Chopra SS; Niehues SM; Felix R
    Radiologe; 2005 Jun; 45(6):520-8. PubMed ID: 15912323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of sulfur hexafluoride microbubbles for contrast-enhanced ocular ultrasonography of the pecten oculi in birds.
    Ferreira TAC; Fornazari G; Saldanha A; Lunardeli B; Moore BA; Montiani-Ferreira F
    Vet Ophthalmol; 2019 Jul; 22(4):423-429. PubMed ID: 30109756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authors reply.
    Cui XW; Dietrich CF
    Ultraschall Med; 2015 Feb; 36(1):74-5. PubMed ID: 25802905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.